Issued Patents All Time
Showing 101–125 of 126 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 5705163 | Target-specific, cytotoxic, recombinant pseudomonas exotoxin | Vijay K. Chaudhary, David Fitzgerald | 1998-01-06 |
| 5705156 | Psuedomonas exotoxins of low animal toxicity and high cytocidal activity | David Fitzgerald, Vijay K. Chaudhary | 1998-01-06 |
| 5696237 | Recombinant antibody-toxin fusion protein | David Fitzgerald, Vijay K. Chaudhary, Thomas Waldmann, Cary L. Queen | 1997-12-09 |
| 5635599 | Fusion proteins comprising circularly permuted ligands | Robert Kreitman, Raj K. Puri | 1997-06-03 |
| 5614191 | IL-13 receptor specific chimeric proteins and uses thereof | Raj K. Puri, Waldemar Debinski, Nicholas Obiri | 1997-03-25 |
| 5612032 | Method for diagnosing tumors using mouse monoclonal antibodies | Mark C. Willingham | 1997-03-18 |
| 5608039 | Single chain B3 antibody fusion proteins and their uses | Mark C. Willingham, David Fitzgerald, Ulrich Brinkmann, Lee Pai | 1997-03-04 |
| 5602095 | Recombinant pseudomonas exotoxin with increased activity | David Fitzgerald | 1997-02-11 |
| 5587455 | Cytotoxic agent against specific virus infection | Edward A. Berger, Bernard Moss, Thomas R. Fuerst, David Fitzgerald, Tamio Mizukami +1 more | 1996-12-24 |
| 5525337 | Monoclonal antibody binding cell surface antigens for diagnosing cancer | Mark C. Willingham, Kai Chang | 1996-06-11 |
| 5512658 | Pseudomonas exotoxins (PE) and conjugates thereof having lower animal toxicity with high cytocidal activity through substitution of positively charged amino acids | David Fitzgerald, Vijay K. Chaudhary | 1996-04-30 |
| 5489525 | Monoclonal antibodies to prostate cells | — | 1996-02-06 |
| 5458878 | P. exotoxin fusio proteins have COOHG220101al alterations which increase cytotoxicity | Vijay K. Chaudhary, David Fitzgerald | 1995-10-17 |
| 5428143 | Cytotoxic agent against specific virus infection | Edward A. Berger, Bernard Moss, Thomas R. Fuerst, David Fitzgerald, Tamio Mizukami +1 more | 1995-06-27 |
| 5328984 | Recombinant chimeric proteins deliverable across cellular membranes into cytosol of target cells | Prior Trevor, David Fitzgerald, Waldemar Debinski, Clay B. Siegall | 1994-07-12 |
| 5320956 | Monoclonal antibody useful for the diagnosis of cancer | Mark C. Willingham, Kai Chang | 1994-06-14 |
| 5242813 | Mouse monoclonal antibodies specific for normal primate tissue, malignant human cultural cell lines human tumors | Mark C. Willingham | 1993-09-07 |
| 5206352 | Compositions for clones containing DNA sequences associated with multidrug resistance in human cells | Igor B. Roninson, Michael M. Gottesman | 1993-04-27 |
| 5206353 | CD-4/cytotoxic gene fusions | Edward A. Berger, Bernard Moss, Thomas R. Fuerst, David Fitzgerald, Tamio Mizukami +1 more | 1993-04-27 |
| 5166059 | Gene therapy using gene fusions for genetic or acquired disorders | Michael M. Gottesman | 1992-11-24 |
| 5082927 | Selectively cytotoxic IL-4-PE40 fusion protein | David Fitzgerald, Masato Ogata | 1992-01-21 |
| 4958009 | Anti-human ovarian cancer immunotoxins and methods of use thereof | Michael J. Bjorn, David Fitzgerald, Arthur E. Frankel, Walter J. Laird, David B. Ring +2 more | 1990-09-18 |
| 4892827 | Recombinant pseudomonas exotoxins: construction of an active immunotoxin with low side effects | Sankar Adhya, David Fitzgerald | 1990-01-09 |
| 4806494 | Monoclonal antibody against ovarian cancer cells (OVB-3) | David Fitzgerald, Mark C. Willingham | 1989-02-21 |
| 4545985 | Pseudomonas exotoxin conjugate immunotoxins | Mark C. Willingham, David Fitzgerald | 1985-10-08 |